Locations
United States · Portland, OR, USA · Miami, FL, USA · Beaverton, OR, USA · Oregon City, OR, USA · Greenway, Beaverton, OR, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
Stage
Other
founded in
2018
First Ascent Biomedical is a biotech start-up founded in 2018, focused on transforming medical oncology through individualized treatment planning technologies. Their flagship product, the Drug Prediction Platform, utilizes advanced AI and therapy-resistant cell technologies to create personalized cancer treatment plans, significantly improving patient outcomes and accelerating drug development. The platform integrates functional drug testing, DNA/RNA sequencing, and AI-guided tumor mapping, providing actionable plans to physicians in an average of 10 days. With a strong emphasis on validation studies and partnerships with leading cancer centers, First Ascent Biomedical is positioned to reshape cancer treatment and reduce healthcare costs by minimizing ineffective therapies.
Is this your company?
Something looks off?
